Microglial activation by purines and pyrimidines - PubMed (original) (raw)

Review

. 2002 Nov;40(2):156-163.

doi: 10.1002/glia.10150.

Affiliations

Review

Microglial activation by purines and pyrimidines

Kazuhide Inoue. Glia. 2002 Nov.

Abstract

in English, German

Microglial activation by purines and pyrimidines is reviewed, with emphasis on the actions of adenosine 5'-triphosphate (ATP) on chemotaxis or releases of plasminogen and cytokines from microglia. ATP activates microglia, causing morphological changes with membrane ruffling. Activated microglia exhibit chemotaxis to ATP. Microglia stimulated by a low concentration of ATP (approximately 30-50 microM) rapidly release plasminogen (within 5-10 min), which may protect neurons. Microglia stimulated by a higher concentration of ATP release tumor necrosis factor-alpha (TNF-alpha), 2-3 h after the stimulation and interleukin-6 (IL-6), 6 h after the stimulation. It is reported that TNF-alpha stimulation causes an increase in the expression of IL-6 receptor mRNA and expression in neuronal cells (März et al. 1996. Brain Res 706:71-79). After binding with gp130, the IL-6 receptor matures and can accept IL-6 molecules. It is speculated that neurons may require several hours to prepare for the full reception of IL-6, which induces a more efficient protective effect by IL-6 after stimulation with TNF-alpha. After neurons are ready to accept IL-6 fully, microglia release IL-6 to neurons. Stronger and longer stimulation by ATP may change the function of microglia and cause cell death. The conditions evoking the heavy stimulation would result from serious injury. Activated microglia act as scavenger cells that induce apoptosis in damaged neurons by releasing toxic factors, including NO, and removing dead cells, their remnants, or dangerous debris by phagocytosis. These actions lead to a suitable environment for tissue repair and neural regeneration. The fate of neurons may therefore be regulated in part by ATP through the activation of microglia.

Microglial activation by purines and pyrimidines is reviewed, with emphasis on the actions of adenosine 5′-triphosphate (ATP) on chemotaxis or releases of plasminogen and cytokines from microglia. ATP activates microglia, causing morphological changes with membrane ruffling. Activated microglia exhibit chemotaxis to ATP. Microglia stimulated by a low concentration of ATP (∼30-50 μM) rapidly release plasminogen (within 5-10 min), which may protect neurons. Microglia stimulated by a higher concentration of ATP release tumor necrosis factor-α (TNF-α), 2-3 h after the stimulation and interleukin-6 (IL-6), 6 h after the stimulation. It is reported that TNF-α stimulation causes an increase in the expression of IL-6 receptor mRNA and expression in neuronal cells (März et al. 1996. Brain Res 706:71-79). After binding with gp130, the IL-6 receptor matures and can accept IL-6 molecules. It is speculated that neurons may require several hours to prepare for the full reception of IL-6, which induces a more efficient protective effect by IL-6 after stimulation with TNF-α. After neurons are ready to accept IL-6 fully, microglia release IL-6 to neurons. Stronger and longer stimulation by ATP may change the function of microglia and cause cell death. The conditions evoking the heavy stimulation would result from serious injury. Activated microglia act as scavenger cells that induce apoptosis in damaged neurons by releasing toxic factors, including NO, and removing dead cells, their remnants, or dangerous debris by phagocytosis. These actions lead to a suitable environment for tissue repair and neural regeneration. The fate of neurons may therefore be regulated in part by ATP through the activation of microglia. GLIA 40:156-163, 2002.

Copyright 2002 Wiley-Liss, Inc.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Allan SM, Rothwell NJ. 2001. Cytokines and acute neurodegeneration. Nature Rev Neurosci 2: 734-744.
    1. Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP. 1995. Tumor necrosis factors α and β protect neurons against amyloid β-peptide toxicity: evidence for involvement of a κB-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 92: 9328-9332.
    1. Berghe WV, Plaisance S, Boone E, Bosscher KD, Schumitz ML, Fier W, Haegeman G. 1998. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273: 3285-3290.
    1. Blanchard DK, Wei S, Duan C, Pericle F, Diaz JI, Djeu JY. 1995. Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cells. Blood 85: 3173-3182.
    1. Brosnan CF, Selmaji K, Raine CS. 1988. Hypothesis: a role for tumor necrosis factor in immune-related demyelination and its relevance to multiple sclerosis. J Neuroimmunol 18: 87-94.

Publication types

MeSH terms

Substances

LinkOut - more resources